Skip to main content
SpringerLink
Log in

Effects of selective If-channel inhibition with ivabradine on hemodynamics in a patient with restrictive cardiomyopathy

  • Clinical Correspondence
  • Published:
Clinical Research in Cardiology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

References

  1. Diaz A, Bourassa MG, Guertin MC, Tardif JC (2005) Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease. Eur Heart J 26:967–974

    Article  PubMed  Google Scholar 

  2. Flannery G, Gehrig-Mills R, Billah B, Krum H (2008) Analysis of randomized controlled trials on the effect of magnitude of heart rate reduction on clinical outcomes in patients with systolic chronic heart failure receiving beta-blockers. Am J Cardiol 101:865–869

    PubMed  CAS  Google Scholar 

  3. Kannel WB, Kannel C, Paffenbarger RS Jr, Cupples LA (1987) Heart rate and cardiovascular mortality: the Framingham Study. Am Heart J 113:1489–1494

    Article  PubMed  CAS  Google Scholar 

  4. Gibbons RJ, Abrams J, Chatterjee K, Daley J, Deedwania PC, Douglas JS, Ferguson TB Jr, Fihn SD, Fraker TD Jr, Gardin JM, O’Rourke RA, Pasternak RC, Williams SV (2003) ACC/AHA 2002 guideline update for the management of patients with chronic stable angina—summary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Management of Patients With Chronic Stable Angina). J Am Coll Cardiol 41:159–168

    Article  PubMed  Google Scholar 

  5. Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, Dallongeville J, De Backer G, Ebrahim S, Gjelsvik B, Herrmann-Lingen C, Hoes A, Humphries S, Knapton M, Perk J, Priori SG, Pyorala K, Reiner Z, Ruilope L, Sans-Menendez S, Op Reimer WS, Weissberg P, Wood D, Yarnell J, Zamorano JL, Walma E, Fitzgerald T, Cooney MT, Dudina A, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Funck-Brentano C, Filippatos G, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Altiner A, Bonora E, Durrington PN, Fagard R, Giampaoli S, Hemingway H, Hakansson J, Kjeldsen SE, Larsen ML, Mancia G, Manolis AJ, Orth-Gomer K, Pedersen T, Rayner M, Ryden L, Sammut M, Schneiderman N, Stalenhoef AF, Tokgozoglu L, Wiklund O, Zampelas A (2007) European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil 14(Suppl 2):E1–40

    Article  PubMed  Google Scholar 

  6. Fox K, Ford I, Steg PG, Tendera M, Ferrari R (2008) Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial. Lancet 372:807–816

    Article  PubMed  CAS  Google Scholar 

  7. Mulder P, Barbier S, Chagraoui A, Richard V, Henry JP, Lallemand F, Renet S, Lerebours G, Mahlberg-Gaudin F, Thuillez C (2004) Long-term heart rate reduction induced by the selective I(f) current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure. Circulation 109:1674–1679

    Article  PubMed  CAS  Google Scholar 

  8. Werdan K (2008) Die SHIFT-studie. In: Münzel T (ed) Bedeutung der Herzfrequenz in der Therapie kardiovaskulärer Erkrankungen. UNI-MED Verlag AG, Bremen, pp 52–54

    Google Scholar 

  9. Selvanayagam JB, Hawkins PN, Paul B, Myerson SG, Neubauer S (2007) Evaluation and management of the cardiac amyloidosis. J Am Coll Cardiol 50:2101–2110

    Article  PubMed  CAS  Google Scholar 

  10. Artz G, Wynne J (2000) Restrictive Cardiomyopathy. Curr Treat Options Cardiovasc Med 2:431–438

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

We thank Dr. Fernando Bittinger (Department for Pathology, University Hospital Mainz) for the careful analysis of the myocardial biopsy samples and Dr. Karl-Friedrich Kreitner (Department for Radiology, University Hospital Mainz) for the assistance in cardiac MRI data acquisition.

Author information

Authors and Affiliations

  1. Universitätsmedizin der Johannes-Gutenberg-Universität Mainz, II. Medizinische Klinik—Kardiologie, Angiologie und Internistische Intensivmedizin, Langenbeckstr. 1, 55131, Mainz, Germany

    Philip Wenzel, Nico Abegunewardene & Thomas Münzel

Authors
  1. Philip Wenzel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nico Abegunewardene
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Thomas Münzel
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Philip Wenzel.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wenzel, P., Abegunewardene, N. & Münzel, T. Effects of selective If-channel inhibition with ivabradine on hemodynamics in a patient with restrictive cardiomyopathy. Clin Res Cardiol 98, 681–684 (2009). https://doi.org/10.1007/s00392-009-0057-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00392-009-0057-6

Keywords

Search

Navigation